Document is current
Any future updates will be listed below
-
Authors
Batignes, Maxime https://orcid.org/0000-0002-2383-840X
Luka, Marine
Jagtap, Surabhi
de Cevins, Camille https://orcid.org/0000-0002-5370-850X
Nemazanyy, Ivan https://orcid.org/0000-0001-8080-839X
Leib, Jacqueline
Fali, Tinhinane
Pierga, Alexandre
Zarhrate, Mohammed
García-Paredes, Víctor
Carbone, Francesco https://orcid.org/0009-0002-0819-4471
Pérot, Brieuc P.
Neven, Bénédicte
Bader-Meunier, Brigitte
Quartier, Pierre
Hully, Marie
Belot, Alexandre https://orcid.org/0000-0003-4902-5332
Lepelley, Alice https://orcid.org/0000-0001-8656-7291
Frémond, Marie-Louise https://orcid.org/0000-0002-2798-9141
Fischer, Alain https://orcid.org/0000-0003-4025-5983
Ménager, Mickaël M. https://orcid.org/0000-0002-6838-2389
- License Information
-
More Information
Article History
Received: 4 November 2025
Accepted: 11 February 2026
First Online: 3 March 2026
Competing interests
: M.M.M. and M.B. are listed as inventors on a patent application related to this article (Application no. WO2024/165507), entitled “Use of HIF-1 stabilizing agents for the treatment of type I interferonopathies”. The remaining authors declare no competing interests.
